A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

CenExel ACT- Anaheim Clinical Trials /ID# 280481, Anaheim, California

Acpru /Id# 280382, Grayslake, Illinois